Takebishi Corporation (JP:7510)
:7510
Top Page
Takebishi Corporation
(7510)
Select Model
Select Model
Rating:75Outperform
Price Target:
¥2,642.00
▲(18.63% Upside)
Action:UpgradedDate:03/01/26
The score is driven primarily by strong underlying financial stability and profitability (especially the balance sheet), supported by a clear technical uptrend. These positives are tempered by weaker cash flow conversion and an overextended momentum signal (high RSI), while valuation and dividend are reasonably supportive.
Positive Factors
Strong balance sheet and low leverage
A low debt-to-equity profile and robust equity ratio provide durable financial flexibility: supports funding of system integration projects, cushions cyclical semiconductor/FA demand, enables opportunistic capex or M&A, and lowers solvency risk over the next 2-6 months.
Negative Factors
Weak operating cash conversion
Persistent weakness and volatility in cash conversion risks liquidity for a working-capital intensive distribution and project business. Over 2-6 months this can constrain project funding, limit reinvestment, and pressure short-term solvency despite strong reported equity.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong balance sheet and low leverage
A low debt-to-equity profile and robust equity ratio provide durable financial flexibility: supports funding of system integration projects, cushions cyclical semiconductor/FA demand, enables opportunistic capex or M&A, and lowers solvency risk over the next 2-6 months.
Read all positive factors
Takebishi Corporation (7510) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥38.28B
Dividend Yield3.02%
Average Volume (3M)25.87K
Price to Earnings (P/E)9.8
Beta (1Y)0.80
Revenue Growth7.09%
EPS Growth13.13%
CountryJP
Employees813
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)N/A
Shares Outstanding16,028,000
10 Day Avg. Volume15,470
30 Day Avg. Volume25,873
Financial Highlights & Ratios
PEG Ratio1.77
Price to Book (P/B)0.71
Price to Sales (P/S)0.29
P/FCF Ratio16.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Takebishi Corporation Business Overview & Revenue Model
Company Description
Takebishi Corporation, a technological trading company, deals in industrial electric machinery and electronic equipment in Japan. The company offers industrial factory automation (FA) equipment, including controllers, drive controls, and electrici...
How the Company Makes Money
Takebishi primarily makes money by selling industrial/FA products and related solutions to corporate customers. Key revenue streams include: (1) Product sales through its role as a trading/distribution partner for automation and industrial compone...
Takebishi Corporation Financial Statement Overview
Summary
Income Statement
78
Positive
Balance Sheet
84
Very Positive
Cash Flow
65
Positive
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 103.05B | 100.97B | 101.36B | 97.40B | 81.60B | 63.57B |
| Gross Profit | 14.70B | 14.37B | 14.11B | 13.84B | 12.17B | 9.78B |
| EBITDA | 4.57B | 4.40B | 4.47B | 4.78B | 3.69B | 2.40B |
| Net Income | 2.42B | 2.66B | 2.50B | 2.74B | 2.09B | 1.34B |
Balance Sheet | ||||||
| Total Assets | 60.61B | 63.69B | 65.13B | 64.08B | 59.15B | 49.32B |
| Cash, Cash Equivalents and Short-Term Investments | 9.46B | 8.97B | 8.23B | 6.49B | 6.05B | 8.79B |
| Total Debt | 1.33B | 1.50B | 1.73B | 5.09B | 2.87B | 1.70B |
| Total Liabilities | 19.77B | 22.84B | 26.05B | 28.46B | 25.97B | 19.38B |
| Stockholders Equity | 40.81B | 40.82B | 39.06B | 35.59B | 33.17B | 29.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.72B | 5.97B | -898.00M | -1.18B | 2.78B |
| Operating Cash Flow | 0.00 | 1.82B | 6.08B | -716.00M | -890.00M | 3.14B |
| Investing Cash Flow | 0.00 | -95.00M | -84.00M | -191.00M | -3.81B | -981.00M |
| Financing Cash Flow | 0.00 | -1.31B | -4.42B | 1.20B | 2.05B | -660.00M |
Takebishi Corporation Technical Analysis
Neutral
2227.00
Price Trends
2432.06
Negative
2279.24
Positive
2095.50
Positive
Market Momentum
-4.99
Positive
41.05
Neutral
2.47
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7510, the sentiment is Neutral. The current price of 2227 is below the 20-day moving average (MA) of 2508.45, below the 50-day MA of 2432.06, and above the 200-day MA of 2095.50, indicating a neutral trend. The MACD of -4.99 indicates Positive momentum. The RSI at 41.05 is Neutral, neither overbought nor oversold. The STOCH value of 2.47 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7510.
Takebishi Corporation Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥59.02B | 10.45 | ― | 2.87% | 10.24% | 61.61% | |
77 Outperform | ¥480.98B | 13.81 | ― | 0.79% | 15.38% | -26.84% | |
75 Outperform | ¥38.28B | 9.78 | ― | 3.02% | 7.09% | 13.13% | |
70 Outperform | ¥67.82B | 15.74 | 5.37% | 3.41% | -12.80% | 4.26% | |
66 Neutral | ¥82.97B | 8.78 | ― | 2.41% | 16.05% | 3.58% | |
64 Neutral | ¥415.34B | 14.59 | ― | 2.87% | 8.99% | -43.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
* Technology Sector Average
JP:7510
Takebishi Corporation
2,401.00
562.65
30.61%
JP:8084
Ryoden
3,380.00
905.01
36.57%
JP:2737
Tomen Devices Corp.
12,740.00
6,907.57
118.43%
JP:3132
MACNICA HOLDINGS INC.
2,330.00
458.94
24.53%
JP:6323
Rorze Corporation
2,732.00
1,181.20
76.17%
JP:7609
Daitron Co., Ltd.
2,783.00
1,187.06
74.38%
Takebishi Corporation Corporate Events
Takebishi Lifts Full-Year Earnings and Dividend Outlook on Strong Medical and Semiconductor Demand
Feb 26, 2026
Takebishi Corporation has raised its full-year consolidated earnings forecast for the fiscal year ending March 2026, citing robust demand for its core medical equipment, including radiation cancer treatment systems and CT/MRI diagnostic devices, a...
Takebishi Lifts Nine-Month Profit and Confirms Outlook with Higher Dividend
Jan 30, 2026
Takebishi Corporation reported strong results for the nine months ended 31 December 2025, with net sales rising 13.5% year on year to ¥81.98 billion and operating profit jumping 31.7% to ¥3.22 billion, while profit attributable to owners...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.